Community-Led Action Research in Oncology: Pandemic-Appropriate Radiotherapy Innovations Evaluated (CLARO PARTE) for Latin America and the Caribbean Countries.

Autor: Riano I; Division of Hematology and Oncology, Dartmouth Cancer Center, Dartmouth Health, Geisel School of Medicine at Dartmouth, Lebanon, NH., Alas-Pineda C; Division of Radiation Oncology, Liga Contra El Cáncer, San Pedro Sula, Honduras., Reyes Garcia S; Division of Radiation Oncology, Liga Contra El Cáncer, San Pedro Sula, Honduras., Murillo R; Centro Javeriano de Oncología, Hospital Universitario San Ignacio, Faculty of Medicine, Pontificia Universidad Javeriana, Bogotá, Colombia., Gutiérrez-Delgado F; Centro de Estudios y Prevención del Cáncer, Latin American School of Oncology, Tuxtla Gutiérrez, México., Cazap E; Latin-American and Caribbean Society of Medical Oncology (SLACOM), Buenos Aires, Argentina., Pais Viegas CM; Department of Radiation Oncology, Instituto Nacional de Cáncer, Brazil National Cancer Institute, Rio de Janeiro, Brazil., Torre M; Division of Oncology, Hospital de Clínicas, Universidad de Buenos Aires, Buenos Aires, Argentina., Barahona KC; Division of Radiation Oncology, International Cancer Center, Diagnostic Hospital, San Salvador, El Salvador., Sarria GJ; Dirección General de Control de Cancer, Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru., Del Castillo Bahi R; Department of Radiation Oncology, Instituto Nacional de Oncología y Radiobiología, La Habana, Cuba., Luongo-Céspedes Á; Instituto Nacional de Cáncer, Montevideo, Uruguay., Ovalles B; Department of Radiation Oncology, Centro de Cancer Homs, Santiago de los Caballeros, Dominican Republic., Umaña Herrera FV; Department of Radiation Oncology, Caja Costarricense de Seguro Social (CCSS), San José, Costa Rica., Sánchez R; Centro Javeriano de Oncología, Hospital Universitario San Ignacio, Faculty of Medicine, Pontificia Universidad Javeriana, Bogotá, Colombia., McVorran S; Department of Radiation Oncology and Applied Science, Dartmouth Cancer Center, Lebanon, NH., Williams B; Department of Radiation Oncology and Applied Science, Dartmouth Cancer Center, Lebanon, NH., Kascmar J; Department of Surgery, Dartmouth Health, Geisel School of Medicine at Dartmouth, Lebanon, NH., Kennedy LS; Strategic Initiatives & Global Oncology at the Dartmouth Cancer Center, Dartmouth Health, Lebanon, NH., Lyons KD; Department of Occupational Therapy, Massachusetts General Hospital (MGH) Institute of Health Professions, Boston, MA., Bejarano S; Division of Radiation Oncology, Liga Contra El Cáncer, San Pedro Sula, Honduras., Wong SL; Department of Surgery, Dartmouth Cancer Center, Dartmouth Health, Geisel School of Medicine at Dartmouth, Lebanon, NH.; The Dartmouth Institute for Health Policy and Clinical Practice, Geisel School of Medicine at Dartmouth, Lebanon, NH.

Publikováno v: JCO global oncology [JCO Glob Oncol] 2024 Aug; Vol. 10, pp. e2400051.

Nimotuzumab plus radiotherapy for unresectable squamous-cell carcinoma of the head and neck

Autor: Rivero Tc, Patricia Lorenzo Luaces, Galainena Jj, Carmen Viada, Mullens, M. Frómeta, Bárbara Wilkinson, Bilbao Ma, Muchuli Cr, de Armas El, Tania Crombet, Kirenia Perez, Rodríguez E, Mulén B, I. Leonard, Normando Iznaga, Gracias E, Rodríguez Mo, Pineda I, Jose Alert, Vinageras En, Olga Torres, del Castillo Bahi R

Publikováno v: Cancer biologytherapy. 9(5)

The prognosis of patients with advanced head and neck cancer remain dismal. For this tumor type, elevated levels of EGFR are associated with a shorter disease free survival and time to treatment failure, reflecting a more aggressive phenotype. Nimotu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7002d0dd25af525a49a9c1c06b5997ef
https://pubmed.ncbi.nlm.nih.gov/20448462

Indian clinical practice consensus guidelines for the management of laryngeal cancer: Update 2022.

Autor: Singhal, Manish¹ (AUTHOR), Prabhash, Kumar² (AUTHOR) kumarprabhashtmh@gmail.com, Babu, K. Govind³ (AUTHOR), Chaturvedi, Pankaj⁴ (AUTHOR), Kuriakose, Moni⁵ (AUTHOR), Birur, Praveen⁶ (AUTHOR), Anand, Anil K.⁷ (AUTHOR), Kaushal, Ashish⁸ (AUTHOR), Mahajan, Abhishek⁹ (AUTHOR), Syiemlieh, Judita¹⁰ (AUTHOR), Gairola, Munish¹¹ (AUTHOR), Ramachandra, Prakash¹² (AUTHOR), Goyal, Sumit¹³ (AUTHOR), John, Subashini¹⁴ (AUTHOR), Nayyar, Rohit¹⁵ (AUTHOR), Patil, Vijay M.¹⁶ (AUTHOR), Rao, Vishal¹⁷ (AUTHOR), Noronha, Vanita² (AUTHOR), Roshan, Vikas¹⁸ (AUTHOR), Rath, G. K.¹⁹ (AUTHOR)

Publikováno v: Cancer Research, Statistics & Treatment. 2024 Supplement, Vol. 7, pS22-S26. 5p.

Indian clinical practice consensus guidelines for the management of oropharyngeal cancer: Update 2022.

Autor: Noronha, Vanita¹ (AUTHOR), Prabhash, Kumar¹ (AUTHOR) kumarprabhashtmh@gmail.com, Babu, K Govind² (AUTHOR), Chaturvedi, Pankaj³ (AUTHOR), Kuriakose, Moni⁴ (AUTHOR), Birur, Praveen⁵ (AUTHOR), Anand, Anil K⁶ (AUTHOR), Kaushal, Ashish⁷ (AUTHOR), Mahajan, Abhishek⁸ (AUTHOR), Syiemlieh, Judita⁹ (AUTHOR), Singhal, Manish¹⁰ (AUTHOR), Gairola, Munish¹¹ (AUTHOR), Ramachandra, Prakash¹² (AUTHOR), Goyal, Sumit¹³ (AUTHOR), John, Subashini¹⁴ (AUTHOR), Nayyar, Rohit¹⁵ (AUTHOR), Patil, Vijay M¹⁶ (AUTHOR), Rao, Vishal¹⁷ (AUTHOR), Roshan, Vikas¹⁸ (AUTHOR), Rath, G.K.¹⁹ (AUTHOR)

Publikováno v: Cancer Research, Statistics & Treatment. 2024 Supplement, Vol. 7, pS12-S16. 5p.

Nimotuzumab plus radiotherapy for unresectable squamous-cell carcinoma of the head and neck.

Autor: Rodríguez MO; National Institute of Oncology and Radiobiology, Havana, Cuba., Rivero TC, del Castillo Bahi R, Muchuli CR, Bilbao MA, Vinageras EN, Alert J, Galainena JJ, Rodríguez E, Gracias E, Mulén B, Wilkinson B, de Armas EL, Pérez K, Pineda I, Frómeta M, Leonard I, Mullens V, Viada C, Luaces P, Torres O, Iznaga N, Crombet T

Publikováno v: Cancer biology & therapy [Cancer Biol Ther] 2010 Mar 01; Vol. 9 (5), pp. 343-9. Date of Electronic Publication: 2010 Mar 20.